Get the Stockscreener App
6.03
0.42%
0.025
After Hours:
5.95
-0.08
-1.33%
Biovie Inc stock is traded at $6.03, with a volume of 33,164.
It is up +0.42% in the last 24 hours and up +547.69% over the past month.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
See More
Previous Close:
$6.005
Open:
$6
24h Volume:
33,164
Relative Volume:
0.09
Market Cap:
$11.15M
Revenue:
-
Net Income/Loss:
$-25.56M
P/E Ratio:
-1.1596
EPS:
-5.2
Net Cash Flow:
$-19.35M
1W Performance:
-19.39%
1M Performance:
+547.69%
6M Performance:
+265.45%
1Y Performance:
+58.56%
1-Day Range:
$5.7356
$6.20
1-Week Range:
$5.7356
$7.7493
52-Week Range:
$0.62
$9.56
Biovie Inc Stock (BIVI) Company Profile
Name
Biovie Inc
Sector
Industry
Phone
775-888-3162
Address
680 W NYE LANE, CARSON CITY
Compare BIVI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIVI
Biovie Inc
|
6.03 | 11.15M | 0 | -25.56M | -19.35M | -5.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Biovie Inc Stock (BIVI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-22-22 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-15-21 | Initiated | B. Riley Securities | Buy |
Biovie Inc Stock (BIVI) Latest News
What are the latest earnings results for BioVie Inc.Chart Pattern Forecasts For Consistent Profits - jammulinksnews.com
How strong is BioVie Inc. company’s balance sheetDaily Trading Signals That Work - jammulinksnews.com
What makes BioVie Inc. stock price move sharplyExpert Picks Tracker For Beginners - jammulinksnews.com
Why BioVie Inc. stock attracts strong analyst attentionValue Driven Trading Forecast Analysis - beatles.ru
When is BioVie Inc. stock expected to show significant growthChart Pattern Insights Backed By Experts - jammulinksnews.com
What institutional investors are buying BioVie Inc. stockChart Pattern Ideas For Fast Growth - jammulinksnews.com
What are BioVie Inc. company’s key revenue driversEarnings Report Alerts To Watch Now - jammulinksnews.com
Intraday Charts Show Spike in BioVie Inc. ActivityTrade Timing Strategy With Technical Data Explained - metal.it
Trading Bots Trigger Alerts on BioVie Inc. ActivityWeekly Top Gainers Forecast Watchlist Released - metal.it
Traders Consider Averaging Down in BioVie Inc.Conservative Entry for High Return Setup Backed - metal.it
Is BioVie Inc. stock overvalued or undervaluedWealth Building Target Finder To Watch Now - jammulinksnews.com
What catalysts could drive BioVie Inc. stock higher in 2025Smart Portfolio Data Feed For 2025 - jammulinksnews.com
Published on: 2025-07-28 22:20:34 - metal.it
How high can BioVie Inc. stock price go in 2025Entry and Exit Strategy Optimizer Tool Tested - metal.it
Should I hold or sell BioVie Inc. stock in 2025Build wealth steadily with expert advice - jammulinksnews.com
Does BioVie Inc. stock perform well during market downturnsRapid wealth multiplication - jammulinksnews.com
What is BioVie Inc. company’s growth strategyAchieve breakthrough financial results today - jammulinksnews.com
What are the technical indicators suggesting about BioVie Inc.Capitalize on fast-moving trading opportunities - jammulinksnews.com
How many analysts rate BioVie Inc. as a “Buy”Unstoppable trading performance - jammulinksnews.com
How does BioVie Inc. compare to its industry peersFind market-beating stocks for your portfolio - jammulinksnews.com
What is the risk reward ratio of investing in BioVie Inc. stockFree Capital Allocation Plans - jammulinksnews.com
What is the dividend policy of BioVie Inc. stockTrack stocks with high upside potential easily - jammulinksnews.com
Is it the right time to buy BioVie Inc. stockFree Stock Selection - jammulinksnews.com
Published on: 2025-07-27 07:54:24 - metal.it
Published on: 2025-07-26 14:40:51 - metal.it
Is BioVie Inc. a good long term investmentAccelerated earnings growth - PrintWeekIndia
What analysts say about BioVie Inc. stockConsistently high returns - Autocar Professional
Is BioVie Inc. stock overhyped or has real potentialTremendous wealth creation - jammulinksnews.com
Biovie stock rises after drug shows age deceleration in Alzheimer’s patients - Investing.com India
BioVie Presented Data Highlighting that Patients Treated - GlobeNewswire
What drives BioVie Inc. stock priceUnprecedented market success - Autocar Professional
Biovie shares climb as Alzheimer’s drug shows promising age deceleration effects - MSN
BioVie presents data on Bezisterim at WCAG-2025 - TipRanks
BioVie Inc. Presents Promising Phase 3 Study Results for Bezisterim in Alzheimer’s Disease at WCAG-2025 - Quiver Quantitative
Breakthrough: New Alzheimer's Drug Bezisterim Reverses Aging Across 10 Biological Markers, Trial Data Reveals - Stock Titan
Biovie Inc Stock (BIVI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):